Respiratory Medicine
Volume 104, Issue 7 , Pages 1050-1056, July 2010

Risk factors for pneumonia in immunocompromised patients with influenza

  • David Schnell

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Julien Mayaux

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Cédric de Bazelaire

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Jérôme Legoff

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Séverine Feuillet

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Catherine Scieux

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Juliette Andreu-Gallien

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Michael Darmon

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • André Baruchel

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Benoit Schlemmer

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
  • ,
  • Élie Azoulay

      Affiliations

    • AP-HP, Hôpital Saint-Louis, Medical ICU, 1 avenue Claude Vellefaux, 75010 Paris, France
    • University Paris-7 Paris-Diderot, UFR de Médecine, 75010 Paris, France
    • Corresponding Author InformationCorresponding author at: AP-HP, Hôpital Saint-Louis, Réanimation médicale, 1 avenue Claude Vellefaux, 75010 Paris, France. Tel.: +33 142 499 421; fax: +33 142 499 426.

Received 12 August 2009; accepted 28 January 2010. published online 25 February 2010.

Summary 

Background

Immunocompromised patients with influenza are at higher risk of pneumonia and death. However, risk factors for progression to pneumonia still need evaluation.

Methods

Retrospective study in immunocompromised patients with influenza-related respiratory infections. Risk factors for pneumonia were identified by multivariable logistic regression.

Results

We identified 100 immunocompromised patients infected with influenza (68 hematological malignancies, 11 HIV, 21 iatrogenic immunosuppression). Immunofluorescence was positive in 95% of patients, mainly on nasopharyngeal aspirates (84%). Influenza A virus was involved in 80% of patients. Associated infection was documented in 34 patients. All patients presented with upper respiratory tract infection and 53 progressed to pneumonia. Thirty-two patients were critically ill, 11 received mechanical ventilation, and 10 died. All the patients who died had pneumonia. Patients with pneumonia were older (46y (36–63) vs. 33y (13–51), P=0.003) and more often had influenza A (89% vs. 70%, P=0.04) and associated infection (56% vs. 9%, P<0.0001). Factors independently associated with progression to pneumonia were influenza A (OR 5.54, 95% CI [1.16–26.47]) and hematological malignancies (OR 3.85, 95% CI [1.1–14.5]).

Conclusions

In our cohort of hospitalized immunocompromised patients, influenza progresses to pneumonia in more than half the patients. Patients with hematological malignancies and influenza A infection are at higher risk for pneumonia and should be included in preemptive antiviral therapy trials.

Keywords: Influenza, Acute respiratory failure, Pneumonia, Bone marrow transplantation, Lymphoma, Bronchoscopy

Abbreviations: ARDS, acute respiratory distress syndrome, BAL, bronchoalveolar lavage, CI, confidence interval, CT, computed tomography, HIV, human immunodeficiency virus, HSCT, hematopoietic stem cell transplantation, ICU, intensive care unit, MDCK cells, Madin–Darby canine kidney cells, NPA, nasopharyngeal aspirates, OR, odds ratio, SAPSII, simplified acute physiologic score II, URTI, upper respiratory tract infection

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(10)00049-1

doi:10.1016/j.rmed.2010.01.021

Respiratory Medicine
Volume 104, Issue 7 , Pages 1050-1056, July 2010